| Bioactivity | PSB-CB5 is a potent and selective antagonist of GRP18. PSB-CB5 has the potential for the research of metabolic disease and obesity[1]. | |||||||||
| Name | PSB-CB5 | |||||||||
| CAS | 1627710-30-8 | |||||||||
| Formula | C20H17ClN2O2S | |||||||||
| Molar Mass | 384.88 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Kotańska M, et al. Effects of GPR18 Ligands on Body Weight and Metabolic Parameters in a Female Rat Model of Excessive Eating. Pharmaceuticals (Basel). 2021;14(3):270. |
PSB-CB5
CAS: 1627710-30-8 F: C20H17ClN2O2S W: 384.88
PSB-CB5 is a potent and selective antagonist of GRP18. PSB-CB5 has the potential for the research of metabolic disease a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.